CD86 and neoplasm: For infiltrating TAMs, after adjustment for tumor purity, in LIHC, FUNDC1 was positively correlated with CD80 and CD86, and in LUSC, FUNDC1 negatively correlated with CD80, indicating the constitutive effect of TAMs on differences in tumor cell survival (Table 1).